Diagnostic Hepatitis B virus-sAg (HBV-sAg) antibodies (anti-Hepatitis B virus-sAg, anti-HBV-sAg) for infectious disease HBV-sAg detection in ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Catalog Number: GMP-HBV-sAg-Ab
HBsAg?(also known as the?Australia antigen) is the surface?antigen?of the?hepatitis B virus?(HBV). It indicates current?hepatitis B?infection. The viral envelope of an enveloped virus has different surface proteins from the rest of the virus which act as antigens. These antigens are recognized by antibody proteins that bind specifically to one of these surface proteins.
Today, these antigen-proteins can be genetically manufactured (e.g. transgene E. coli) to produce material for a simple antigen test, which detects the presence of HBV.
It is present in the sera of patients with viral hepatitis B (with or without clinical symptoms). Patients who developed antibodies against HBsAg (anti-HBsAg seroconversion) are usually considered non-infectious. HBsAg detection by immunoassay is used in blood screening, to establish a diagnosis of hepatitis B infection in the clinical setting (in combination with other disease markers) and to monitor antiviral treatment.
In histopathology, the presence of HBsAg is more commonly demonstrated by the use of the Shikata orcein technique, which uses a natural dye to bind to the antigen in infected liver cells.
Positive HBsAg tests can be due to recent vaccination against Hepatitis B virus but this positivity is unlikely to persist beyond 14 days post-vaccination.
Genemedi produces core diagnostic ingredients for test of infectious disease and related syndrome.
GeneMedi offers paired diagnostics grade Hepatitis B virus-sAg (HBV-sAg) ) antibodies (monoclonal antibody, mab) and Hepatitis B virus-sAg (HBV-sAg) ) antigens for infectious disease rapid test kit of Hepatitis B virus-sAg (HBV-sAg) ) testing in ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
All the antibodies and antigens for infectious disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody.The antigens can be used for antibodies rapid test of infectious disease.
Order information
Catalog No. | Size | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-HBV-sAg-Ab-1 | Size:1mg | 1953 | ||
GMP-HBV-sAg-Ab-1 | Size:10mg | 13671 | ||
GMP-HBV-sAg-Ab-1 | Size:100mg | 95697 | ||
GMP-HBV-sAg-Ab-2 | Size:1mg | 1953 | ||
GMP-HBV-sAg-Ab-2 | Size:10mg | 13671 | ||
GMP-HBV-sAg-Ab-2 | Size:100mg | 95697 | ||
GMP-HBV-sAg-Ab | ≥100mg | Inquiry | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
Cat No. | GMP-HBV-sAg-Ab-1; GMP-HBV-sAg-Ab-2 |
Product Name | Anti-Hepatitis B virus-sAg (HBV-sAg) mouse monoclonal antibody(mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Hepatitis B virus-sAg (HBV-sAg) protein binding, ELISA validated as capture antibody and detection antibody. Pair in HBV-sAglevel test and infectious disease evaluation. |
Tag | mFc |
Products description | Anti-Hepatitis B virus-sAg (HBV-sAg) mouse monoclonal antibody(mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Specics | mouse |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]